DIAGNOS Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DGNOF research report →
Companywww.diagnos.ca
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.
- CEO
- Andre Larente
- IPO
- 2003
- Employees
- 22
- HQ
- Brossard, QC, CA
Price Chart
Valuation
- Market Cap
- $14.37M
- P/E
- -4.99
- P/S
- 298.90
- P/B
- 15.70
- EV/EBITDA
- -5.37
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -2090.86%
- Op Margin
- -6415.81%
- Net Margin
- -6907.32%
- ROE
- 3086.87%
- ROIC
- -129.23%
Growth & Income
- Revenue
- $103.80K · -39.00%
- Net Income
- $-4,286,449 · -37.36%
- EPS
- $-0.05 · -13.29%
- Op Income
- $-3,811,093
- FCF YoY
- -69.17%
Performance & Tape
- 52W High
- $0.29
- 52W Low
- $0.13
- 50D MA
- $0.18
- 200D MA
- $0.21
- Beta
- -0.17
- Avg Volume
- 85.42K
Get TickerSpark's AI analysis on DGNOF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DGNOF Coverage
We haven't published any research on DGNOF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DGNOF Report →